Literature DB >> 9373613

Methotrexate pneumonitis in a patient with rheumatoid arthritis.

R Clearkin1, P A Corris, S H Thomas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9373613      PMCID: PMC2431424          DOI: 10.1136/pgmj.73.863.603

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  7 in total

Review 1.  Methotrexate in rheumatoid arthritis: toxicity issues.

Authors:  M E Weinblatt
Journal:  Br J Rheumatol       Date:  1996-05

2.  Pulmonary alveolitis and NSAIDs--fact or fiction?

Authors:  J C Weber; W K Essigman
Journal:  Br J Rheumatol       Date:  1986-02

Review 3.  Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent?

Authors:  S Tariq; S M Tariq
Journal:  Postgrad Med J       Date:  1993-10       Impact factor: 2.401

Review 4.  Methotrexate-related pulmonary complications in rheumatoid arthritis.

Authors:  P Barrera; R F Laan; P L van Riel; P N Dekhuijzen; A M Boerbooms; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1994-07       Impact factor: 19.103

Review 5.  Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature.

Authors:  G Searles; R J McKendry
Journal:  J Rheumatol       Date:  1987-12       Impact factor: 4.666

6.  Occurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis.

Authors:  P Hilliquin; M Renoux; S Perrot; X Puéchal; C J Menkès
Journal:  Br J Rheumatol       Date:  1996-05

7.  Pulmonary function in patients receiving long-term low-dose methotrexate.

Authors:  V Cottin; J Tébib; B Massonnet; P J Souquet; J P Bernard
Journal:  Chest       Date:  1996-04       Impact factor: 9.410

  7 in total
  2 in total

1.  Methotrexate pneumonitis precipitated by NSAIDs--can fish oil help?

Authors:  M Thulasimani; S Ramaswamy
Journal:  Postgrad Med J       Date:  1998-06       Impact factor: 2.401

Review 2.  [Treatment of rheumatic diseases and pulmonary toxicity].

Authors:  J Schreiber; U Müller-Ladner
Journal:  Pneumologe (Berl)       Date:  2018-09-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.